Home
Enanta Pharmaceuticals

Enanta Pharmaceuticals Market Share Analysis for November 2025

Great Chemistry Cures

Health > Biotechnology and Pharmaceuticals

Domainenanta.com

Year Founded1995

Employees51 - 200

Annual Revenue$75M - $100M

Enanta Pharmaceuticals

Enanta Pharmaceuticals (including company regionals)

enanta.com

See more website traffic and engagement information

Enanta Pharmaceuticals Revenue up to November 2025 is 75M - 100M

revenue generated by Enanta Pharmaceuticals top domains

Enanta Pharmaceuticals top domains revenue over 3 years

Revenue for Enanta Pharmaceuticals top domains

enanta.com75M - 100M

See more with Sales Intelligence

Total visits to Enanta Pharmaceuticals's top domains

Understand Enanta Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

enanta.com3.2K

See more with Sales Intelligence

Avg. visit duration in Enanta Pharmaceuticals's top domains

Analyze Enanta Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

enanta.com00:00:10

See more with Sales Intelligence

Avg. pageviews on Enanta Pharmaceuticals's top domains

See how Enanta Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

enanta.com1.68

See more with Sales Intelligence

Enanta Pharmaceuticals top competitors by domain

Top similar sites in November 2025, ranked by their affinity

hcvadvocate.orgCompany NameHCV Advocate.orgEmployees51 - 200HQUnited States, Florida, North MiamiAnnual revenue$10M - $15MTotal visits--Health > Health Conditions and Concerns

Top technologies used by Enanta Pharmaceuticals

These are the website technologies, by industry, used by Enanta Pharmaceuticals top domains

Widget (5)

Twemoji

Marketing (4)

Google Marketing Platform

Advertising (2)

PubMatic

Audio Video Media (2)

YouTube

More Technologies

10

See all

News & Signals from Enanta Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEnanta Pharmaceuticals, Inc attended event IDWeek 2025 on Oct 22nd '25.At IDWeek 2025, held on 19 - 22 October, Dr John P DeVincenzo from Enanta Pharmaceuticals presented data from a Phase IIa human challenge study for the company's investigational respiratory syncytial virus (RSV) therapeutic, a first-in-class once-daily, orally administered L-protein inhibitor.

NewsHengrui identified as competitor of Enanta Pharmaceuticals, Inc.- Hengrui differentiates itself through dual-pathway targeting, advanced clinical stages, and regulatory expertise, competing against STAT6-focused rivals like Kymera and Enanta.

NewsEnanta Pharmaceuticals, Inc hires Harry R. Trout as interim CFO.- Enanta Pharmaceuticals appoints Harry R. Trout as interim CFO, ensuring continuity during Paul Mellett's medical leave, leveraging his 23-year experience in structuring key transactions.